We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Efficacy of Albuterol SPIROMAX® in Patients With Exercise-Induced Bronchoconstriction

- Exercise-Induced Bronchoconstriction (EIB)
- Completed

Study Title: Efficacy of Albuterol SPIROMAXֲ® in Adult and Adolescent Patients With Exercise-Induced Bronchoconstriction (EIB)

Teva Identifier: ABS-AS-302

ClinicalTrials.gov Identifier: NCT01791972

Study Status: Completed

Trial Condition(s): Exercise-Induced Bronchoconstriction (EIB)

Interventions: Drug: Albuterol Spiromax | Drug: Placebo Spiromax

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age Range: 18 Years to 50 Years

Trial Duration: 03/01/2013 - 06/01/2013

Phase: Phase 3

Study Type

Interventional